ILK and cancer: As many genotoxic chemotherapies are known to induce cellular senescence in normal cells [32], these studies suggest inhibition of ILK activity can be used as a more specific senescence inducer in cancer cells, as the survival and growth of these cancerous cells are addicted to activated ILK function.